Abstract: A tube winding bobbin is accommodated in a segment pocket of a centrifugation transfer device in which a blood bag system is set. The blood bag system is provided with a plurality of sealed tubes which extend for a predetermined length and which have an occluded lumen therein. The tube winding bobbin has a winding part around which the plurality of sealed tubes are wound, a pair of side parts connected to both ends of the winding part, and an engagement part engageable with a wall part constituting the segment pocket.

Abstract: An object of the invention is to provide a means for accomplishing inactivation of a pathogen in a blood sample containing red blood cells and platelets together, as well as sufficiently reducing the hemolysis rate of the red blood cell product finally obtained. The means is to irradiate ultraviolet ray to a blood sample containing red blood cells and platelets in the presence of a hemolysis inhibitor and a surfactant having an HLB value of 13 or greater and having the number of oxyethylene groups of a hydrophilic portion in the molecular structure of 20 or greater when producing a blood product containing red blood cells and platelets.

Abstract: Red blood cell storage container includes: a container body made of a resin composition consisting of at least one of: polyolefin polymer, polyamide polymer, polyurethane polymer, polystyrene polymer, polybutadiene polymer, polyester polymer, fluoropolymer, polycarbonate polymer, polyacrylic polymer, and polysulfone polymer; and a coating part formed on an inner surface of the coating body and made of diamond-like carbon.

Abstract: A blood storage container includes a container main body made of a resin composition incorporating, per 100 parts by mass of polyvinyl chloride, 30 to 70 parts by mass of a composite plasticizer combining a first plasticizer and a second plasticizer, the first plasticizer being di-isononyl-cyclohexane-1,2-dicarboxylate, the second plasticizer being a citrate, the blending ratio between the first plasticizer and the second plasticizer in the composite plasticizer being 15/85 to 93/7.

Abstract: The main object of the present invention is to provide a novel compound which has a VEGF receptor tyrosine kinase inhibitory activity and is useful as an active ingredient for the treatment of diseases accompanying angiogenesis or edema, for example, age-related macular degeneration or the like. The present invention includes, for example, an alkynyl indazole derivative represented by the following general formula (I), a pharmaceutical acceptable salt thereof, and a medicine containing thereof.

Abstract: The main object of the present invention is to provide a novel compound which has a VEGF receptor tyrosine kinase inhibitory activity and is useful as an active ingredient for the treatment of diseases accompanying angiogenesis or edema, for example, age-related macular degeneration or the like. The present invention includes, for example, an alkynyl indazole derivative represented by the following general formula (I), a pharmaceutical acceptable salt thereof, and a medicine containing thereof.

Abstract: The invention relates to a conductive paste composition useful in the manufacture of photovoltaic cell electrodes, especially electrodes contacting the p-type emitter of an n-type base cell. The paste composition may comprise a source of a conductive metal, a glass frit such as a lead borate, aluminum metal powder, and a boron source that may be at least one of elemental boron, a non-oxide, boron-containing substance, or a combination thereof, all dispersed in an organic vehicle that renders the composition suitable for screen printing or other like application method. Also provided are a semiconductor device such as a photovoltaic cell having an electrode made with the paste composition, and a method for its manufacture.

Abstract: A red blood cell preservative includes: a first aqueous solution containing mannitol, adenine, sodium citrate, sodium dihydrogen phosphate, and dextrose; and a second aqueous solution containing disodium phosphate, characterized in that the first aqueous solution and the second aqueous solution are mixed together after autoclave sterilization.

Abstract: A method of manufacturing a solar cell electrode comprising steps of: preparing an N-type solar cell substrate, wherein the N-type solar cell substrate comprises an n-doped semiconductor substrate, a p-type emitter formed on one side of the semiconductor substrate, and a passivation layer formed on the p-type emitter; stencil printing a conductive paste onto the passivation layer through a printing mask, the conductive paste comprising, (i) 60 to 95 wt % of a conductive powder, (ii) 0.4 to 3.0 wt % of an aluminum powder, (iii) 0.1 to 10 wt % of a glass frit, (iv) 3 to 30 wt % of an organic medium, (v) 0.4 to 1.7 wt % of an amide compound, based on the total weight of the conductive paste; and firing the applied conductive paste to form a solar cell electrode in electric contact with the p-type emitter.

Abstract: Provided are an excipient system and a medical container for an erythrocyte enriched liquid. The excipient system is prepared by adding a hemolysis inhibitor and a surfactant to an erythrocyte storage solution. Herein, the surfactant has an HLB value of 13 or more, and the number of oxyethylene groups at a hydrophilic segment in the molecular structure of the surfactant is 20 or more. The inside of the medical container is filled with the excipient system for an erythrocyte enriched liquid.

Abstract: A method of manufacturing a p-type electrode of a solar cell comprising: (a) preparing an n-type semiconductor substrate comprising an n-type base layer, a p-type emitter and a passivation layer formed on the p-type emitter; (b) applying a conductive paste onto the passivation layer, wherein the conductive paste comprises, (i) 100 parts by weight of a conductive powder, (ii) 1 to 12 parts by weight of a lead-free glass frit comprising, 20 to 33 mol. % of Bi2O3, 25 to 40 mol. % of B2O3, 15 to 45 mol. % of ZnO, 0.5 to 9 mol. % of alkaline-earth metal oxide, alkali metal oxide or a mixture thereof, wherein the mot % is based on the total molar fraction of each component in the glass frit, and (iii) 5 to 40 parts by weight of an organic medium; and (c) firing the applied conductive paste.

Abstract: Red blood cell storage container includes: a container body made of a resin composition consisting of at least one of: polyolefin polymer, polyamide polymer, polyurethane polymer, polystyrene polymer, polybutadiene polymer, polyester polymer, fluoropolymer, polycarbonate polymer, polyacrylic polymer, and polysulfone polymer; and a coating part formed on an inner surface of the coating body and made of diamond-like carbon.

Abstract: A method of manufacturing an n-type electrode comprising the steps of: preparing an N-type base semiconductor substrate, comprising an n-base layer, a p-type emitter on the n-base layer, a first passivation layer on the p-type emitter, and a second passivation layer on the n-base layer; applying a conductive paste onto the second passivation layer on the n-base layer, wherein the conductive paste comprises, (i) 100 parts by weight of a conductive powder, (ii) 0.1 to 10 parts by weight of an aluminum powder with particle diameter of 2 to 12 ?m, (iii) 3.5 to 25 parts by weight of a glass frit, and (iv) an organic medium; and firing the conductive paste at temperature of 910° C. or lower.

Abstract: Provided are an excipient system and a medical container for an erythrocyte enriched liquid. The excipient system is prepared by adding a hemolysis inhibitor and a surfactant to an erythrocyte storage solution. Herein, the surfactant has an HLB value of 13 or more, and the number of oxyethylene groups at a hydrophilic segment in the molecular structure of the surfactant is 20 or more. The inside of the medical container is filled with the excipient system for an erythrocyte enriched liquid.

Abstract: The invention relates to a method of manufacturing a p-type electrode comprising the steps of: preparing an N-type base semiconductor substrate comprising an n-base layer, a p-type emitter on the n-base layer, a first passivation layer on the p-type emitter, and a second passivation layer on the n-base layer; applying a conductive paste onto the first passivation layer, wherein the conductive paste comprises (i) 100 parts by weight of a conductive powder comprising a metal selected from the group consisting of silver, nickel, copper and a mixture thereof, (ii) 0.3 to 8 parts by weight of aluminum powder with particle diameter of 3 to 11 ?m, (iii) 3 to 22 parts by weight of a glass frit, and (iv) an organic medium; and firing the conductive paste.

Abstract: To obtain low resistance and high adhesion at the same time in a solar cell electrode, a conductive paste is offered. A conductive paste for solar cell electrode contains conductive powder, organic medium and glass frit which is mixture of more than one kind of glass frit such as a mixture of glass frit containing at least PbO and glass frit containing at least Bi2O3.

Abstract: The invention relates to a method of manufacturing a solar cell electrode comprising steps of: (a) preparing a semiconductor substrate comprising a negative layer, a positive layer and passivation layers formed on the negative layer and the positive layer; (b) applying a conductive paste onto the passivation layer(s) formed on the positive layer, on the negative layer, or on both of the positive layer and the negative layer, wherein the conductive paste comprises; (i) a conductive powder; (ii) a glass frit comprising 45 to 81 mole percent (mol %) of PbO, 1 to 38 mol % of SiO2 and 5 to 47 mol % of B2O3, based on the total molar fraction of each component in the glass frit; and (iii) a resin binder; and (c) firing the conductive paste.

Abstract: To obtain low resistance and high adhesion at the same time in a solar cell electrode, a conductive paste is offered. A conductive paste for solar cell electrode contains conductive powder, organic medium and glass frit which is mixture of more than one kind of glass frit such as a mixture of glass frit containing at least PbO and glass frit containing at least Bi2O3.

Abstract: The present invention attempts to establish a method for surface-fixing single-walled carbon nanotubes having a desired chirality highly selected from among the single-walled carbon nanotubes having various chiralities, and utilizes the method to provide an array of the carbon nanotubes for electronic devices. The present invention attempts also to provide a carbon nanotube composition including carbon nanotubes having a single chiral vector (n, m) at a purity of more than 50% based on the unit of number wherein n and m are integers, and a method for manufacturing the same.